City

Clinical trials near Madrid, Spain

Active studies with a listed research site in Madrid, Spain.

17active studies

7recruiting now

24countries represented

69largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Obesity, Weight GainCondition

Tirzepatide, PlaceboTreatment

Argentina, Australia69 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06439277See eligibility →

Recruiting nowPhase 3

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Overweight, ObesityCondition

Semaglutide, PlaceboTreatment

Belgium, Bulgaria62 locations

Novo Nordisk A/SSponsor

Updated 2026-08-18 · NCT07770841See eligibility →

Recruiting nowNot applicable

Safety and Effectiveness of Orbera365™ Intragastric Balloon System

ObesityCondition

Intragastric BalloonTreatment

Czechia, Spain4 locations

Boston Scientific CorporationSponsor

Updated 2026-08-13 · NCT07062094See eligibility →

Recruiting nowNot applicable

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver FibrosisCondition

Intervention not listedTreatment

Spain1 locations

Hospital General Universitario Gregorio MarañonSponsor

Updated 2026-06-22 · NCT07658755See eligibility →

Recruiting nowNot applicable

"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"

Metabolic Syndrome, Obesity PreventionCondition

energy reduced Mediterranean diet (25% caloric restriction) plus physical activity program, Usual CareTreatment

Spain1 locations

IMDEA FoodSponsor

Updated 2026-03-27 · NCT06857929See eligibility →

Recruiting nowNot applicable

Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

Monogenic ObesityCondition

Semaglutide (administered by PDS290 pen-injector)Treatment

France, Germany7 locations

Prof. Dr. Martin WabitschSponsor

Updated 2026-01-08 · NCT07302802See eligibility →

Recruiting nowNot applicable

The SI! Program Reintervention for Elementary Schools Trial

Cardiovascular Health, ObesityCondition

Reintervention, Late interventionTreatment

Spain1 locations

Foundation for Science, Health and Education, SpainSponsor

Updated 2024-12-04 · NCT06715358See eligibility →

Opening soonNot applicable

NutriTrack: AI-Assisted Nutritional Tracking in the Obesity Clinic

Obesity & OverweightCondition

NutriTrack digital health applicationTreatment

Spain1 locations

Francisco José García GonzálezSponsor

Updated 2026-05-15 · NCT07588620See eligibility →

Opening soonNot applicable

Effect of CPAP Versus APAP in Patients With Obesity Undergoing Bariatric Surgery Protocol

Sleep Apnea, Obstructive, Bariatric SurgeryCondition

In the intervention group, patients will be treated with auto-adjusting APAP, providing variable pressures throughout the sleep hours., CPAPTreatment

Spain1 locations

Hospital Universitario Ramon y CajalSponsor

Updated 2025-07-23 · NCT07001215See eligibility →

Opening soonNot applicable

Obesity Prevention in Children and Young People Treated for Acute Lymphoblastic Leukaemia with ALLTogether

Diet Intervention, Physical Activity InterventionCondition

Diet, Diet and physical activityTreatment

Spain, United Kingdom2 locations

University of ExeterSponsor

Updated 2025-02-26 · NCT06846294See eligibility →

Invitation onlyNot applicable

Cities for Better Health Childhood Obesity Prevention Initiative

ObesityCondition

Community-based intervention packagesTreatment

Australia, Brazil6 locations

Novo Nordisk A/SSponsor

Updated 2026-08-21 · NCT06855563See eligibility →

Invitation onlyNot applicable

A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

ObesityCondition

SemaglutideTreatment

Spain, Switzerland30 locations

Novo Nordisk A/SSponsor

Updated 2026-08-04 · NCT07055607See eligibility →

Invitation onlyNot applicable

A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy

Pregnancy, ObesityCondition

No InterventionTreatment

Spain, United Kingdom3 locations

Novo Nordisk A/SSponsor

Updated 2026-01-14 · NCT05872022See eligibility →

Invitation onlyNot applicable

Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adolescents With Trisomy 21: LiverTy Project

Obesity Prevention, Pediatric ObesityCondition

To evaluate fat liver content in the cases/controls population.Treatment

Spain1 locations

IMDEA FoodSponsor

Updated 2025-05-02 · NCT06888570See eligibility →

Active, not recruitingPhase 2

A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

Type 2 Diabetes MellitusCondition

RO7795081, SemaglutideTreatment

Hungary, Poland50 locations

Hoffmann-La RocheSponsor

Updated 2026-07-07 · NCT07112872See eligibility →

Active, not recruitingPhase 2

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

Diabetes Mellitus, Type 2, Diabetic Peripheral NeuropathyCondition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

Canada, Denmark54 locations

Novo Nordisk A/SSponsor

Updated 2025-12-05 · NCT06797869See eligibility →

Active, not recruitingNot applicable

Interindividual Variation in Response to Green Coffee

Overweight and ObesityCondition

Green coffee, Roasted coffeeTreatment

Spain1 locations

Instituto de Ciencia y Tecnología de Alimentos y NutriciónSponsor

Updated 2024-12-11 · NCT06204445See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Madrid, Spain

Current studies

Related cities